Guru Ownership Trend
Guru Analysis for Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.5 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1 M net outflow during the quarter.
On the selling side, Steven Cohen reduced exposure by 69.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Contineum Therapeutics, Inc. (CTNM)
Major holders include Renaissance Technologies (RenTech) ($1.1 M), Steven Cohen ($422,518). According to the latest reported data, 2 tracked investment managers collectively hold approximately 93,079 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited CTNM. The total reported sell value was $1 M.
No tracked managers opened new positions or increased their holdings in CTNM during the most recent reporting period.